Wegovy® Pill(semaglutide)

WEGOVY® may cause serious side effects, including:

• Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, WEGOVY® and other medicines that work like WEGOVY® caused thyroid tumors, including thyroid cancer. It is not known if WEGOVY® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
• Do not use WEGOVY® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

WEGOVY® tablets are a prescription medicine used with a reduced-calorie diet and increased physical activity to:

• reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
• help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off.

WEGOVY® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.

It is not known if WEGOVY® tablets are safe and effective for use in people under 18 years of age.

• you or any of your family have ever had a type of thyroid cancer called MTC or if you have an endocrine system condition called MEN 2.
• you have had a serious allergic reaction to semaglutide or any of the ingredients in WEGOVY® tablets.

• have or have had problems with your pancreas or kidneys.
• have type 2 diabetes and a history of diabetic retinopathy.
• have or have had depression or suicidal thoughts, or mental health issues.
• are scheduled to have surgery or other procedures that use anesthesia or deep sedation.
• are pregnant or plan to become pregnant. WEGOVY® may harm your unborn baby. You should stop using WEGOVY® 2 months before you plan to become pregnant.
• are breastfeeding or plan to breastfeed.

• Use WEGOVY® exactly as your healthcare provider tells you to.
• Use WEGOVY® with a reduced-calorie diet and increased physical activity.
• Take 1 WEGOVY® tablet by mouth on an empty stomach in the morning with water (no more than 4 ounces).
• Do not split, crush, chew or dissolve WEGOVY® tablets. Swallow WEGOVY® tablets whole.
• After 30 minutes, you can eat, drink, or take other oral medicines.

Serious side effects include: inflammation of pancreas (pancreatitis), gallbladder problems, increased risk of low blood sugar (hypoglycemia), dehydration leading to kidney problems, severe stomach problems, serious allergic reactions, change in vision, increased heart rate, depression or thoughts of suicide.

Most common side effects: nausea, diarrhea, vomiting, constipation, stomach pain, headache, tiredness, upset stomach, dizziness, feeling bloated, belching, gas, heartburn.

WEGOVY® Tablets:

• Store at room temperature between 68°F and 77°F (20°C to 25°C).
• Store tablets in the original closed WEGOVY® bottle until you are ready to take one. Do not store in any other container.
• Store in a dry place away from moisture.

Keep WEGOVY® and all medicines out of the reach of children.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use WEGOVY® for a condition for which it was not prescribed. Do not give WEGOVY® to other people, even if they have the same condition that you have. It may harm them.

Active Ingredient: semaglutide

Inactive Ingredients in WEGOVY® tablets: salcaprozate sodium (SNAC) and magnesium stearate.